Corient Private Wealth
ALT icon

Corient Private Wealth’s Altimmune ALT Stock Holding History

Corient Private Wealth’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Buy
54,226
+23,673
+77% +$70.7K ﹤0.01% 2852
2026
Q1 		$94.1K Buy
+30,553
New +$130K ﹤0.01% 2699

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corient Private Wealth's ALT Position: Q2 2026 in Review

Corient Private Wealth increased its Altimmune (ALT) stake by 77% in Q2 2026, buying an estimated $70.7K and bringing the position to 54,226 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #2852.

Corient Private Wealth first reported a position in ALT in Q1 2026 and has held it in 2 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Corient Private Wealth held 54,226 shares of Altimmune worth $165K as of Q2 2026.
  • Corient Private Wealth bought 23,673 Altimmune shares in Q2 2026, an estimated $70.7K.
  • Altimmune made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2852 holding.
  • Corient Private Wealth first reported a position in Altimmune in Q1 2026 and has held it in 2 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.